From observation to intervention
The decisive open question is whether targeting the microcirculation improves outcomes. Microcirculatory abnormality predicts poor outcome, but prediction is not a treatment target, and no intervention has been shown to improve outcome by correcting microcirculatory flow specifically.
Trials resolving this require a usable bedside measure, an intervention that reliably alters it, and an outcome that matters — and the first of those is only recently approaching practicality.
Automated analysis
Manual analysis of videomicroscopy was the main barrier to clinical use. Automated and semi-automated software returning indices in near real time is the development that would make microcirculation-guided resuscitation testable at all.
Glycocalyx-directed therapy
Protecting or restoring the glycocalyx is an identified target, with candidate approaches including modified fluid strategies and agents limiting shedding. None is established, and the field should be read as preclinical and early translational.
Beyond sepsis
The same mechanisms are implicated in diabetes, chronic kidney disease, hypertension, long-term consequences of severe infection, and perioperative organ injury. Whether microvascular dysfunction is a common final pathway across these, and whether it is modifiable, is a broader and longer-term question.
Methodological needs
Standardised acquisition and analysis protocols so values are comparable between centres. Agreed thresholds for abnormality. Core outcome sets. Without these, a literature of small single-centre studies using different techniques cannot be synthesised.
In short
What to take from this.
- No intervention is established to improve outcome via the microcirculation.
- Automated analysis is the enabling step for clinical trials.
- Read glycocalyx therapeutics as preclinical, not clinical.
Sources
- Consensus guidance on microcirculation assessment and reporting
- Translational literature on glycocalyx protection
This page reflects established understanding as at mid-2026 and is not a current-awareness service. Clinical and regulatory positions change; verify anything decision-relevant against a current source.
Related